The incidence of visual impairment and its determinants in the WHO multinational study of vascular disease in diabetes

Citation
E. Miki et al., The incidence of visual impairment and its determinants in the WHO multinational study of vascular disease in diabetes, DIABETOLOG, 44, 2001, pp. S31-S36
Citations number
41
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
DIABETOLOGIA
ISSN journal
0012186X → ACNP
Volume
44
Year of publication
2001
Supplement
2
Pages
S31 - S36
Database
ISI
SICI code
0012-186X(200109)44:<S31:TIOVIA>2.0.ZU;2-J
Abstract
Aims/hypothesis. Incidence of severe visual impairment and the ultimate pre valence of all grades of impairment were estimated in the 10 centres of the WHO Multinational Study of Vascular Disease in Diabetes (WHO MSVDD) partic ipating in the followup. Methods. Visual function was ascertained at followup in 2994 (77.9%) of the 3845 eligible participating survivors of the 4709 originally recruited for the WHO MSVDD using the same baseline enquiry method. The associations bet ween incident severe visual impairment, follow-up prevalence of all grades of impairment and baseline risk factors were examined by univariate and ste pwise multiple logistic regression analysis. Results. Overall, 8.4 year incidence of severe visual impairment was 1.94% and showed statistically significant univariate correlations with age at di agnosis, diabetes duration, systolic blood pressure, fasting blood glucose and cholesterol, insulin treatment and strongly with baseline retinopathy. Baseline retinopathy, systolic pressure and cholesterol were statistically significant in multivariable analysis. Differences between centres (0.3% to 3.45%) were not significant. Ultimate prevalence of all grades of impairme nt differed between centres and within almost all of them was correlated in multivariable analysis with baseline retinopathy and proteinuria. Conclusion/interpretation. Comparisons of incident severe visual impairment between centres are restricted by selective mortality, low incidence rates and relatively small numbers in each centre but before retinopathy, baseli ne systolic pressure and cholesterol predicted severe visual impairment. Fo llowup prevalence of all degrees of impairment varied among centres and wer e associated with prior retinopathy and renal disease at baseline.